Results 191 to 200 of about 62,685 (235)
Some of the next articles are maybe not open access.

Urothelial Carcinoma

2023
Authoritative and practical, Urothelial Carcinoma: Methods and Protocols, Second Edition serves as a valuable resource to further increase our knowledge on urothelial carcinoma and also to aid research on numerous other cancers.
Annels, Nicola   +70 more
  +5 more sources

Urothelial Carcinoma

Surgical Pathology Clinics, 2022
Urothelial carcinoma (UC) is known to encompass a wide spectrum of morphologic features and molecular alterations. Approximately 15% to 25% of invasive UC exhibits histomorphologic features in the form of "divergent differentiation" along other epithelial lineages, or different "subtypes" of urothelial or sarcomatoid differentiation.
Manju Aron, Ming Zhou
openaire   +3 more sources

Molecular pathology of urothelial carcinoma

Human Pathology, 2021
The current personalized oncology era has witnessed significant efforts to integrate clinical, pathological, and molecular classifications. The growing need for molecular biomarkers to feed personalized oncology, together with the unprecedented wealth of knowledge on the molecular basis of bladder cancer, has led to a novel approach to this disease ...
Antonio Lopez-Beltran   +3 more
openaire   +3 more sources

Urothelial Carcinoma of the Prostate

Urology, 2007
This study was conducted to explore the diagnosis and management of urothelial carcinoma of the prostate in superficial disease and carcinoma in situ, stromal invasion, primary urothelial carcinoma, and urethral recurrence after radical surgery. A consensus conference convened by the World Health Organization (WHO) and the Société Internationale d ...
Juan, Palou   +9 more
openaire   +2 more sources

Glycosaminoglycans in urothelial carcinomas

Urological Research, 1983
The glycosaminoglycan (GAG) content in human urothelial carcinomas was biochemically determined and compared to that of normal urothelium and bladder wall of the calf. The total GAG content was elevated in urothelial carcinomas, and the distribution pattern differed from that of normal urothelium and bladder wall.
H, Rübben   +3 more
openaire   +2 more sources

Avelumab Maintenance for Urothelial Carcinoma

New England Journal of Medicine, 2020
To the Editor: Powles et al. (Sept. 24 issue)(1) report the practice-changing results of the JAVELIN Bladder 100 trial, which assessed the advantage of maintenance avelumab therapy plus best supportive care over best supportive care alone with respect to overall survival among patients with advanced urothelial carcinoma who had had a response to first ...
Mollica V., Rizzo A., Massari F.
openaire   +5 more sources

The origins of urothelial carcinoma

Expert Review of Anticancer Therapy, 2010
It is now widely believed that there are two major pathways for urothelial carcinogenesis. One pathway usually involves mutation of FGF receptor 3 and gives rise to low-grade papillary tumors that frequently recur but seldom invade. By contrast, high-grade urothelial malignancies, including high-grade papillary urothelial carcinoma and urothelial ...
Liang, Cheng   +7 more
openaire   +2 more sources

Epigenetics of Urothelial Carcinoma

2014
Urothelial carcinoma is the most frequent type of bladder cancer. Improvements in diagnostics and therapy of this common tumor are urgently required and need to be based on a better understanding of its biology. Epigenetic aberrations are crucial to urothelial carcinoma development and progression.
Wolfgang A, Schulz   +3 more
openaire   +2 more sources

ARID1A alteration in aggressive urothelial carcinoma and variants of urothelial carcinoma

Human Pathology, 2016
ARID1A mutation leads to loss of the products of this tumor-suppressor gene. Studies demonstrated ARID1A mutation in 20% of stage IV urothelial carcinomas (UCs) with worse prognosis. The expression of ARID1A in aggressive variants of UC is not studied properly.
Jianhong, Li   +4 more
openaire   +2 more sources

Urothelial carcinoma in a mule

Journal of Equine Veterinary Science
Equine bladder neoplasms are rare. This report aimed to describe the clinical signs and treatment of urothelial carcinoma (UC) in a mule. Cystoscopy of a 20-year-old female mule with a one-week history of hematuria and anemia revealed vascular congestion in the mucosa and an intraluminal, pedunculated mass in the dorsal bladder region ...
A C, Valim   +6 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy